|
USP37 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.583840E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.10599999999062E-05 |
| Normal-vs-Stage2 |
1.052010E-01 |
| Normal-vs-Stage3 |
7.746500E-02 |
| Normal-vs-Stage4 |
6.949000E-01 |
| Stage1-vs-Stage2 |
5.621000E-01 |
| Stage1-vs-Stage3 |
3.838800E-01 |
| Stage1-vs-Stage4 |
2.541000E-01 |
| Stage2-vs-Stage3 |
8.877200E-01 |
| Stage2-vs-Stage4 |
5.980200E-01 |
| Stage3-vs-Stage4 |
6.281000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.369600E-04 |
| Normal-vs-AfricanAmerican |
2.099800E-03 |
| Normal-vs-Asian |
1.609840E-02 |
| Caucasian-vs-AfricanAmerican |
8.249600E-01 |
| Caucasian-vs-Asian |
7.857600E-01 |
| AfricanAmerican-vs-Asian |
8.111400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.004499999961E-07 |
| Normal-vs-Female |
9.789800E-01 |
| Male-vs-Female |
6.367500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.032600E-04 |
| Normal-vs-Extreme_Weight |
3.86450000000593E-07 |
| Normal-vs-Obese |
1.940000E-01 |
| Normal-vs-Extreme_Obese |
3.784600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.847400E-01 |
| Normal_Weight-vs-Obese |
7.786000E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.021000E-01 |
| Extreme_Weight-vs-Obese |
2.225900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.852370E-01 |
| Obese-vs-Extreme_Obese |
9.002800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.283200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.246100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.54049999978589E-07 |
| Normal-vs-Age(81-100Yrs) |
2.160900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.271560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.431600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.534020E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.724600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.472300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.179200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.16539999999821E-05 |
| Normal-VS-Type2 PRCC |
2.16029999999812E-05 |
| Normal-VS-KIRP CIMP |
1.291560E-01 |
| Normal-VS-Unclassified PRCC |
6.213600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.714000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.372200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.249180E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.400100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.842200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.871800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.550040E-04 |
| Normal-vs-N1 |
4.472000E-01 |
| Normal-vs-N2 |
5.272000E-02 |
| N0-vs-N1 |
2.964100E-02 |
| N0-vs-N2 |
1.492100E-02 |
| N1-vs-N2 |
7.953800E-01 |
|
|
